Soligenix (SNGX.OB) Completes Enrollment for Phase 1b Clinical Trial of Bioterror Vaccine
Soligenix Inc. is a late-stage biopharmaceutical company focused on developing products to treat potentially fatal side effects of cancer treatments…
Soligenix Inc. is a late-stage biopharmaceutical company focused on developing products to treat potentially fatal side effects of cancer treatments…
In an economy where staff reductions have become the norm, Vicor Technologies has been aggressively hiring, scaling up its sales…
The ERFW chart is going on radar simply because it has found support at this level earlier this year and…
Manhattan Bancorp, the holding company of Bank of Manhattan, N. A. and MBFS Holdings, Inc., which owns a majority interest…
IDO Security, Inc., developer of the innovative MagShoe™ shoe scanning device, announced this morning that the company will be fulfilling…
Access Pharmaceuticals, Inc. announced that it has been awarded seven different government grants, totaling $1.5 million, for the continued development…
Today, Vibato released news regarding the recent implementation of a robust internal controls framework for Worldwide Energy and Manufacturing USA,…
Kansas City Life Insurance Company reported a slight decline in net income for the third quarter of 2010 ending September…
RAM Energy Resources, Inc. reported that the company has signed an agreement to sell oil and gas properties to a…
Today, eDoorways International Corp. announced that they have signed a financing agreement with O.T. Hill and Associates where O.T. will…